Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
TCG Crossover Management | 3.3M | $63M | 0% | Jun 2024 |
|
Artal Group | 2.8M | $53M | 0% | Jun 2024 |
|
Redmile Group | 2.0M | $38M | -1% | Jun 2024 |
|
Logos Global Management | 1.5M | $28M | 0% | Jun 2024 |
|
Deep Track Capital | 1.4M | $26M | -17% | Jun 2024 |
|
Frazier Life Sciences Management | 1.1M | $22M | 0% | Jun 2024 |
|
Nextech Invest | 952k | $18M | 0% | Jun 2024 |
|
Henderson Group | 819k | $16M | 31% | Jun 2024 |
|
Millennium Management | 783k | $15M | 91% | Jun 2024 |
|
Cormorant Asset Management | 625k | $12M | 0% | Jun 2024 |
|
Ikarian Capital | 507k | $3.3M | 100% | Jun 2024 |
|
Aquilo Capital Management | 500k | $9.5M | -13% | Jun 2024 |
|
5AM Venture Management | 476k | $9.0M | 0% | Jun 2024 |
|
Duquesne Family Office | 387k | $7.4M | 0% | Jun 2024 |
|
SG Americas Securities | 343k | $6.2M | 0% | Sep 2024 |
|
Morgan Stanley | 304k | $5.8M | 25% | Jun 2024 |
|
Parkman Healthcare Partners | 290k | $5.5M | 19% | Jun 2024 |
|
Cantor Fitzgerald, L. P. | 248k | $4.7M | 140% | Jun 2024 |
|
Hudson Bay Capital Management | 208k | $4.0M | -25% | Jun 2024 |
|
Nantahala Capital Management | 200k | $3.8M | 0% | Jun 2024 |
|
M28 Capital Management | 185k | $3.5M | -38% | Jun 2024 |
|
Hsbc Holdings | 178k | $3.4M | 0% | Jun 2024 |
|
Octagon Capital Advisors | 176k | $3.3M | -44% | Jun 2024 |
|
Marshall Wace | 149k | $2.8M | 7% | Jun 2024 |
|
Point72 Asset Management | 147k | $2.8M | 1687% | Jun 2024 |
|
Stempoint Capital | 125k | $2.4M | 100% | Jun 2024 |
|
Citadel Advisors | 117k | $2.2M | 174% | Jun 2024 |
|
Two Sigma Investments | 99k | $1.9M | -8% | Jun 2024 |
|
Woodline Partners | 91k | $1.7M | -62% | Jun 2024 |
|
Two Sigma Advisers | 76k | $1.4M | -2% | Jun 2024 |
|
Schonfeld Strategic Advisors | 75k | $1.4M | -44% | Jun 2024 |
|
Citigroup | 58k | $1.1M | 0% | Jun 2024 |
|
Artia Global Partners | 53k | $997k | 0% | Jun 2024 |
|
Renaissance Technologies | 39k | $743k | -62% | Jun 2024 |
|
TD Asset Management | 31k | $559k | 100% | Sep 2024 |
|
Geode Capital Management | 29k | $559k | 31% | Jun 2024 |
|
William Blair $ Company | 25k | $483k | 0% | Jun 2024 |
|
Trexquant Investment | 22k | $414k | 4% | Jun 2024 |
|
Legato Capital Management | 20k | $376k | 100% | Jun 2024 |
|
Rathbones Brothers | 18k | $350k | -7% | Jun 2024 |
|
Y-Intercept | 17k | $326k | 100% | Jun 2024 |
|
Goldman Sachs Group | 16k | $309k | -25% | Jun 2024 |
|
Custom Index Systems | 14k | $262k | -3% | Sep 2024 |
|
Jump Financial | 12k | $235k | -34% | Jun 2024 |
|
Bank of America Corporation | 10k | $190k | -17% | Jun 2024 |
|
Cubist Systematic Strategies | 9.4k | $179k | -74% | Jun 2024 |
|
Quarry | 6.0k | $114k | 100% | Jun 2024 |
|
Barclays | 5.6k | $105k | 0% | Jun 2024 |
|
Royal Bank of Canada | 4.7k | $89k | 100% | Jun 2024 |
|
Values First Advisors | 3.1k | $56k | 100% | Sep 2024 |
|
GAMMA Investing | 859.00 | $16k | 0% | Sep 2024 |
|
Rhumbline Advisers | 469.00 | $8.9k | 3027% | Jun 2024 |
|
Steward Partners Investment Advisory | 100.00 | $1.9k | 0% | Jun 2024 |
|
Lazard Asset Management | 60.00 | $1.0k | -96% | Jun 2024 |
|
Who sold out of Silence Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Lynx1 Capital Management | Mar 2024 | 527k | $11M |
New York State Common Retirement Fund | Jun 2024 | 24k | $457k |
Shay Capital | Mar 2024 | 15k | $327k |
Jpmorgan Chase & Co | Mar 2024 | 9.6k | $208k |
Advisors Preferred | Jun 2024 | 5.3k | $100k |
Qube Research & Technologies | Mar 2024 | 3.9k | $85k |